The briefing
Pharmaceutical Executive examines how the GLP-1 marketplace is shifting from molecule innovation to ownership of the prescription and patient-support journey. Manufacturers, providers, pharmacies, and payers are positioning to drive adherence, access, and value capture.
Original headline
The Battle to Own the GLP-1 Patient Journey